Cellphire has developed a proprietary method for the long-term stabilization of
platelets in the dry state.
Thrombosomes® are currently in a Phase 1 clinical trial. Learn more.
For more Cellphire product development efforts, visit the Our Technology page.
News Releases
May 14, 2020 – Cellphire, the global leader in long-term stabilization and storage of platelets, a...Read More »
(April 21, 2020) – Cellphire, Inc., the global leader in long-term stabilization and storage of pl...Read More »
March 18, 2020 – Cellphire, Inc., the global leader in long-term stabilization and storage of plat...Read More »